CMS Considers Inherent Reasonableness Rule To Lower Pay For Diabetes Test Supplies
This article was originally published in The Gray Sheet
Executive Summary
The use of a relatively obscure CMS fee-adjustment authority rather than competitive bidding to lower Medicare payment for diabetes testing supplies in the retail setting could be precedent setting.